Adocia focuses on developing innovative biopharmaceutical solutions for metabolic diseases such as diabetes and obesity. Through its proprietary BioChaperone technology and structured R&D partnerships, the company works to advance clinical pipeline
Adocia focuses on developing innovative biopharmaceutical solutions for metabolic diseases such as diabetes and obesity. Through its proprietary BioChaperone technology and structured R&D partnerships, the company works to advance clinical pipeline